IS5044A - Aðferð og ný efnasambönd til að nota með henni - Google Patents

Aðferð og ný efnasambönd til að nota með henni

Info

Publication number
IS5044A
IS5044A IS5044A IS5044A IS5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A
Authority
IS
Iceland
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IS5044A
Other languages
English (en)
Inventor
A. Reece Phillip
Geoffrey Watson Keith
Wu Wen-Yang
Jin Betty
Y. Krippner Guy
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO3632A external-priority patent/AUPO363296A0/en
Priority claimed from AUPO8539A external-priority patent/AUPO853997A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of IS5044A publication Critical patent/IS5044A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5044A 1996-11-14 1999-04-30 Aðferð og ný efnasambönd til að nota með henni IS5044A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO3632A AUPO363296A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
AUPO8539A AUPO853997A0 (en) 1997-08-14 1997-08-14 Method and novel compounds for use therein
PCT/AU1997/000771 WO1998021243A1 (en) 1996-11-14 1997-11-13 Method and novel compounds for use therein

Publications (1)

Publication Number Publication Date
IS5044A true IS5044A (is) 1999-04-30

Family

ID=25645315

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5044A IS5044A (is) 1996-11-14 1999-04-30 Aðferð og ný efnasambönd til að nota með henni

Country Status (19)

Country Link
US (1) US6680054B1 (is)
EP (1) EP0951480A4 (is)
JP (1) JP3691075B2 (is)
KR (1) KR20000068986A (is)
CN (1) CN1238783A (is)
AP (1) AP9901531A0 (is)
AU (1) AU732916C (is)
BR (1) BR9714299A (is)
CA (1) CA2271249C (is)
CZ (1) CZ167999A3 (is)
EA (1) EA001603B1 (is)
HU (1) HUP9904009A3 (is)
IL (1) IL129762A0 (is)
IS (1) IS5044A (is)
NO (1) NO992297L (is)
NZ (1) NZ335368A (is)
PL (1) PL333364A1 (is)
TR (1) TR199901081T2 (is)
WO (1) WO1998021243A1 (is)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
AUPR879401A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US8217154B2 (en) * 2005-02-23 2012-07-10 Lipoxen Technologies Limited Activated sialic acid derivatives for protein derivatisation and conjugation
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
EA017957B1 (ru) * 2007-06-25 2013-04-30 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Композиции и способы, ингибирующие грипп
CA2692417C (en) 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
CA2690440A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
WO2009006591A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-n-acetylase and methods for using the same
US20130280204A1 (en) * 2007-08-27 2013-10-24 Massachusetts Institute Of Technology Polymer-Attached Inhibitors of Influenza Virus
US20090076133A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched zanamivir
DK2318832T3 (da) 2008-07-15 2014-01-20 Academia Sinica Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
BRPI1010981A2 (pt) 2009-05-15 2018-12-04 Redx Pharma Ltd "derivados de fármaco redox"
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
PL225045B1 (pl) 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP2970397A2 (en) 2013-03-14 2016-01-20 University Of Washington Through Its Center For Commercialization Polypeptides for treating and/or limiting influenza infection
AU2014248225B2 (en) 2013-04-01 2020-06-25 Becton, Dickinson And Company Methods and kits for the diagnosis of influenza
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
KR20160104727A (ko) 2014-01-16 2016-09-05 아카데미아 시니카 암의 치료 및 검출을 위한 조성물 및 방법
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
KR20170010003A (ko) 2014-05-27 2017-01-25 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
EP4116329A1 (en) 2014-05-27 2023-01-11 Academia Sinica Anti-her2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP2017518989A (ja) 2014-05-27 2017-07-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 抗ｃｄ２０糖操作抗体群およびその使用
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
KR102808936B1 (ko) 2015-11-20 2025-05-15 오스트레일리언 바이오메디컬 컴퍼니 피티와이 리미티드 의학적 용도의 화합물
CN109195996A (zh) 2016-03-08 2019-01-11 中央研究院 N-聚醣及其阵列的模组化合成方法
CA3034057A1 (en) 2016-08-22 2018-03-01 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
KR20210079278A (ko) 2018-09-06 2021-06-29 시다라 세라퓨틱스, 인코포레이티드 바이러스 감염의 치료를 위한 조성물 및 방법
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282950B6 (sk) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
US5221611A (en) 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
WO1994011005A1 (en) * 1992-11-09 1994-05-26 Scientific Dimensions Usa, Inc. Viral attachment inhibitors
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
GB9410817D0 (en) 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
CN100409844C (zh) * 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
IL125662A0 (en) 1996-03-01 1999-04-11 Biota Scient Management Method of detecting influenza virus and compounds for use therein
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
EP0951480A1 (en) 1999-10-27
TR199901081T2 (xx) 1999-08-23
AU732916C (en) 2002-06-06
EP0951480A4 (en) 2004-07-28
PL333364A1 (en) 1999-12-06
WO1998021243A1 (en) 1998-05-22
CA2271249C (en) 2010-07-20
CA2271249A1 (en) 1998-05-22
US6680054B1 (en) 2004-01-20
CN1238783A (zh) 1999-12-15
NO992297L (no) 1999-07-12
HUP9904009A3 (en) 2001-07-30
NO992297D0 (no) 1999-05-12
KR20000068986A (ko) 2000-11-25
AU4857697A (en) 1998-06-03
NZ335368A (en) 2001-08-31
JP2001504876A (ja) 2001-04-10
EA001603B1 (ru) 2001-06-25
EA199900459A1 (ru) 1999-12-29
AU732916B2 (en) 2001-05-03
AP9901531A0 (en) 1999-05-13
IL129762A0 (en) 2000-02-29
BR9714299A (pt) 2000-04-25
CZ167999A3 (cs) 1999-10-13
HUP9904009A2 (hu) 2000-03-28
JP3691075B2 (ja) 2005-08-31

Similar Documents

Publication Publication Date Title
NO970255L (no) Anordning og fremgangsmåte ved avfyringsstyring
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
DE69714395D1 (de) Abziehvorrichtung
DE69821408D1 (de) Multiplikationsverfahren und -vorrichtung
FI965091A7 (fi) Laskentamenetelmä ja -laite
FI974494L (fi) Paikannusmenetelmä ja paikannusjärjestely
EE03939B1 (et) Portatiivse seadme ekraan ja meetod toiteenergia kokkuhoidmiseks selles seadmes
DE69724347D1 (de) Parallele Datenkomprimierung und -dekomprimierung
DE69712234D1 (de) Kodierungsverfahren und -gerät
DE59707845D1 (de) Kryostatmikrotom
FI963172A7 (fi) Kytkentämenetelmä ja laite
NO20006059L (no) Sammensatt element og fremgangsmåte for anvendelse
DE59701724D1 (de) Kristallisationsvorrichtung und -verfahren
FI961913L (fi) Näytön tehonsäästömenetelmä
DE69529809D1 (de) Dekodierungsverfahren und -vorrichtung
DE69731574D1 (de) Kompiliergerät und -verfahren
NO20003268L (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
DE69820485D1 (de) Dekodierungsverfahren und -vorrichtung
FI971245L (fi) Anti-inflammatorinen tekijä, menetelmä sen eristämiseksi sekä sen käyttö
DK0795265T3 (da) Trækindretning
NO985179D0 (no) FremgangsmÕte og system for tale-til-taleomforming
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
DE4481182T1 (de) (Schnee-) Schlitten
DE69733885D1 (de) Nichtlineares hin- und herbewegbares gerät
FR2865535B1 (fr) Penetreur